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Background: Congenital generalized lipodystrophy (CGL) also known as Berardinelli-Seip Congenital Lipodystrophy
(BSCL) is a genetically heterogeneous disorder characterized by loss of adipose tissues, Acanthosis nigricans,
diabetes mellitus, muscular hypertrophy, hepatomegaly and hypertriglyceridemia. There are four subclinical
phenotypes of CGL (CGL1-4) and mutations in four genes AGPAT2, BSCL2, CAV1 and PTRF have been assigned to
each type.
Methods: The study included clinical and molecular investigations of CGL disease in a consanguineous Pakistani
family. For mutation screening all the coding exons including splice junctions of AGPAT2, BSCL2, CAV1 and PTRF
genes were PCR amplified and sequenced directly using an automated DNA sequencer ABI3730.
Results: Sequence analysis revealed a single base pair deletion mutation (c.636delC; p.Tyr213ThrfsX20) in exon 5 of
BSCL2 gene causing a frame shift and premature termination codon.
Conclusion: Mutation identified here in BSCL2 gene causing congenital generalized lipodystrophy is the first report
in Pakistani population. The patients exhibited characteristic features of generalized lipodystrophy, Acanthosis
nigricans, diabetes mellitus and hypertrophic cardiomyopathy.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1913913076864247.
Keywords: Congenital generalized lipodystrophy, BSCL2, Deletion mutation, Pakistani populationBackground
Congenital generalized lipodystrophy (CGL), or Berardinelli-
Seip congenital lipodystrophy (BSCL), is a genetically
heterogeneous disorder characterized by loss of adipose
tissues and sub-cutaneous fats, enlarged fatty liver, hyper-
trophic muscles, Acanthosis nigricans, increased serum
triglyceride level, insulin intolerance or diabetes mellitus.
Pathogenicity of four genes has been reported in four clinic-
ally overlapping phenotypes so far.* Correspondence: mjelani.ibms@kmu.edu.pk
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reproduction in any medium, provided the orThe affected individuals of congenital generalized
lipodystrophy type 1 (CGL1, MIM 608594) are character-
ized by typical poor fat accumulation in the metabolically
active and mechanical adipose tissues. In addition these
patients have special features of lytic bone lesions that are
absent in other forms of CGL [1,2]. Loss-of-function mu-
tations in 1-acylglycerol-3-phosphate-O-Acyltransferase
(AGPAT2, MIM 603100) gene at chromosome 9q34.3
have been assigned to cause CGL1 phenotype [3,4].
Pathogenic variants of homologous to mouse gamma-
3-linked (BSCL2, MIM 606158) gene, located at chromo-
some 11q13, cause congenital generalized lipodystrophy
type 2 (CGL2, MIM 269700) or a seipin-deficient pheno-
type [3,5]. The subcutaneous biopsies examinations of
patients have revealed scattered groups of small adipo-
cytes with low but detectable lipid content [6]. Thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lipodystrophy, hypertrophic cardiomyopathy, higher
rates of mild mental retardation and an earlier onset of
diabetes [7-9].
Mutations in caveolin 1 (CAV1, MIM 601047) gene,
located at chromosome 7q31.3, cause congenital general-
ized lipodystrophy type 3 (CGL3, MIM 612526). Caveolin-
1-deficient patients exhibit unique manifestation of short
stature, hypocalcemia and vitamin D resistance [10]. Re-
cently another form congenital generalized lipodystrophy
type 4 (CGL4, MIM 613327) has also been described
caused by mutations in RNA polymerase 1 and transcript
release factor (PTRF, MIM 603198) gene at chromosome
17q21 [11].
In the present study clinical and molecular analysis of
a four generations consanguineous Pakistani family dem-
onstrating autosomal recessive CGL phenotype was
performed. Direct sequencing of four candidate genes in
a Pakistani family revealed a single base pair deletion
mutation in BSCL2 gene.
Methods
Human subjects
The present four-generation family, exhibiting features
of CGL or BSCL (Figure 1), belonged to Peshawar city of
Khyber Pakhtunkhwa province, Pakistan. The affected
individuals were born to first degree cousins, suggesting
that affected individuals are homozygous for a mutant
allele. All affected and unaffected individuals underwent
examination at the local government hospitals. Prior to
start of study, approval was obtained from Institutional
Review Board (IRB), Khyber Medical University Peshawar,
Pakistan. Informed consent for the study including pres-
entation of photographs was obtained from affected indi-
viduals and their parents for publication. Genomic DNA
extraction and polymerase chain reaction was performed
as described earlier [12].Figure 1 Pedigree drawing of the family exhibiting congenital
generalized lipodystrophy with autosomal recessive mode of
inheritance. Cousin marriage is denoted by double line between the
couple. Samples available for DNA analysis are marked with asterisk.Mutational analysis
Entire coding region and splice junction sites of
AGPAT2, BSCL2, CAV1 and PTRF genes were amplified
by PCR and screened by DNA sequencing for potential
sequence variants. Primer sequences (available on re-
quest) were designed for each exon using Primer3 soft-
ware [13] and checked for specificity using Basic Local
Alignment Search Tool (BLAST; http://www.ncbi.nlm.
nih.gov/blast). Purification of the PCR-amplified DNA
was performed with commercially available kits
(Marligen Biosciences, Rockville MD, USA). Sequencing
of the potential candidate genes was performed using
Big Dye Terminator v3.1 Cycle Sequencing Kit, together
with an ABI Prism 3730 Genetic Analyzer (Applera, Foster
City, CA, USA). Sequence variants were identified via
Bioedit sequence alignment editor version 6.0.7 (www.
mbio.ncsu.edu/BioEdit/bioedit.html).
Results
Clinical features of the affected individuals
Skin
The affected members (IV-1 and IV-3) of the family
showed characteristic features of congenital generalized
lipodystrophy. Both the affected individuals had acanthosis
nigricans (velvety thickening and hyperpigmentation of
the skin) which was more prominent around neck and in
body folds including axillae, anticubital fossae and poplit-
eal fossae. Both the affected individuals had prominent
veins, rough dry skin and umbilical protrusion. Curly and
dry hair was present with mild hypertrichosis over the
scalp (Figure 2a).
Musculoskeletal examinations
Muscular hypertrophy was observed in skeletal muscles
more prominently at arms and shin areas in both the
affected individuals (Figure 2b). Radiological examina-
tions of bones in the affected individuals showed rela-
tively hyper-density of metacarpals, phalanges, sclerotic
hip bones and adjacent portion of both femurs. Slight
hyper-density was observed in skull bone, however, vault
thickness and para-nasal sinuses were normal in both
the affected individuals. Chest X-rays revealed normal
lung fields, normal cardiac shadow with slight hyper-
density of scapulae, humerus and clavicles. Magnetic
Resonance Imaging examination (MRI) of the brain does
not reveal generalized brain atrophy (Figure 2c).
Abdominal and cardiac examinations
Ultrasonography of the abdomen revealed moderate
hepatomegaly with mild splenomegaly in both the
affected individuals. There was no symptom of polycystic
ovarian syndrome in 7 years affected female (VI-3),
however her 11 years affected brother (VI-1) had moder-
ate genital enlargement. Both the patients exhibited
Figure 2 Clinical features of the patient (IV-1) with congenital generalized lipodystrophy. (a) Note curly scalp hair, hypodontia, abdominal
distension, acanthosis nigricans, velvety thickening and hyperpigmentation of the skin around neck, in axillae and antecubital fossae (b) Hypertrophic
muscles over calves and acanthosis nigricans in the popliteal fossae (c) Magnetic Resonance Imaging showing no exaggeration of the external or
internal cerebrospinal fluid (CSF) spaces suggesting that brain atrophy is not evident.
Table 1 Biochemistry profile of the affected individuals
S. No. Test Patient VI-1 Patient VI-3
Liver function
1 Serum bilirubin 0.7 mg/dl 0.9 mg/dl
2 Serum glutamate pyruvate
transferase
143 U/L 135 U/L
3 Alkaline phosphatase 911 U/L 717 U/L
Lipid profile
4 Triglyceride 394 mg/dl 406 mg/dl
5 Cholesterol 155 mg/dl 196 mg/dl
6 High density lipids 14 mg/dl 34 mg/dl
7 Low density lipids 77 mg/dl 129 mg/dl
Serum electrolytes
8 Na+ 141 144
9 K+ 3.71 3.99
10 Cl- 105.1 108.5
Sugar level
11 Fasting serum glucose 124 mg/dl 51 mg/dl
12 HbA1C 6.5% 5.6%
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of both the affected individuals showed sinus rhythm and
right bundle branch pattern. Echocardiography of IV-1 re-
vealed patent foramen ovale and mild left ventricular
hypertrophy with intact inter-ventricular septum, while
IV-3 showed small secundum atrial septal defect with left
to right shunt, minimal right ventricular dilatation, and an
intact inter-ventricular septum. There was no significant
atrio-ventricular valve re-gurge. The left ventricular func-
tion was found normal (data not shown).
Biochemistry tests
The total serum bilirubin and serum electrolytes levels
of both the affected individuals were within the normal
range. Serum glutamate pyruvate, blood sugar, alkaline
phosphatase and triglyceride levels were raised in both
the affected individuals. High density lipoprotein levels
were low in both the affected individuals than normal in
both of them. The glycosylated hemoglobin (HbA1C)
level of the affected individual IV-1 was slight higher
than controlled diabetic range while that of IV-3 was in
the non-diabetic level (Table 1).
Study limitations
The patients did not cooperate for tissue biopsy there-
fore histo-pathological examinations of the skin and
sural nerves were not performed.
Mutation screening
To search for potential sequence variants, all coding
exons and splice junction sites of AGPAT2, BSCL2,
CAV1 and PTRF genes were sequenced initially in two
affected and one unaffected individuals of the family. A
homozygous deletion mutation of a single base cytosine
at complementary DNA position 636 (c.636delC) was
detected in exon 5 of BSCL2 gene in both the affectedindividuals (Figure 3). This deletion probably shifted the
reading frame leading to a premature stop codon and
adding 20 non-specific amino acid residues BSCL2 pro-
tein (p.Tyr213ThrfsX20). Mutation analysis of BSCL2
exon 5 revealed c.636del in heterozygous state in obli-
gate carriers and phenotypically unaffected individuals of
the family. To ensure that c.636delC does not represent
a neutral polymorphism in this population, a panel of
100 unrelated and ethnically matched control individuals
was screened for this mutation, thus confirming that
mutation was not present outside the family.
Figure 3 Sequence analysis of a single base pair deletion mutation
in BSCL2 gene (c.636delC). (a) DNA sequencing of exon 5 in an
affected individual IV-1 (b) parent or carrier III-1 (c) unaffected or
normal individual.
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Loss-of-function mutations in the BSCL2 gene cause a
severe form of lipodystrophy, whilst characteristic gain-
of-function mutations are believed to be associated
with aggregation of unfolded protein in endoplasmic
reticulum resulting in neurodegeneration leading to a
heterogeneous group of neuropathies [5]. The study
presented here was a four generations consanguineous
family, originated from Peshawar city Pakistan. Clinical
features of the affected individuals resembled CGL2
phenotype. Moreover the first degree consanguinity of the
parents and autosomal recessive mode of inheritance of
the disease phenotype was a definite clue for a homozy-
gous mutation. Mutations in BSCL2 leading to CGL2
phenotype have been identified worldwide [5,14-16].
The generalized loss of adipose tissue, increased trigly-
ceride levels and steatosis of the liver were comparable to
a homozygous mutation p.Tyr213ThrfsX20 identified in
an Indian family [5]. Early onset diabetes mellitus present
in our patients were comparable with homozygous non-
sense mutations identified in Chinese and severe insulin
resistance in Japanese and Brazilian patients [9,14,15],
however we did not perform the insulin resistance test in
our patients. The hypertrophic cardiomyopathy identifiedin our cases was less severe as compared to Chinese
patient caused by homozygous nonsense mutation [17].
There was mild mental retardation (IQ score 65–75) in
both of our patients but the brain MRI did not reveal
brain atrophy.
The variable features of neuropathies are mostly asso-
ciated with heterozygous mutations in BSCL2 dHMN,
Charcot-Marie-Tooth (CMT) and Silver syndromes
[16,18,19]. In 2005, based on disease allele penetrance
and severity of phenotype caused by heterozygous muta-
tions in BSCL2 gene p.N88S in Austrian and German
families, these patients were classified into six subclinical
groups with overlapping features of HMN, CMT and
Silver syndrome [20]. However, in 2009, Brusse et al.
discovered a digenic inheritance of hereditary motor
neuropathy in a large Dutch family with heterozygous
mutation p.N88S in the BSCL2 gene and segregating
autosomal dominant disease haplotype at chromosome
16p [21]. The phenotypic variability ranged from strictly
neuropathic weakness to a spastic paraplegia with her-
editary motor neuropathy presenting clinical phenotype
similar to Silver syndrome [21]. Very recently another
heterozygous mutation p.S90W identified in two Korean
CMT type 2 disease patients [22] was associated with in-
creased density of myelinated fibers. However, this fea-
ture was slightly different from the previously reported
mutation p.S90L in three Italian patients representing
CMT type 2 phenotype with pyramidal signs and sub-
clinical sensory involvement on sural nerve biopsy [23].
Human BSCL2 gene encodes 398 or 462 amino acids
seipin protein from either of the three transcripts 1.6 kb,
1.8 kb and 2.2 kb [24]. The 1.8 kb transcript is exclu-
sively expressed in brain and testis while the other two
are ubiquitously expressed [18]. Seipin protein is located
in endoplasmic reticulum acting as a regulator of lipid
catabolism and is essential for the differentiation of fat
cells [18,24]. Studies have revealed role of seipin in proper
lipid storage and regulation of cAMP/PKA-mediated
lipolysis in adipose differentiation [25,26]. In adult mice
brain bscl2 expression studies have suggested the possible
involvement of seipin in central regulation of energy
balance.
According to UniprotKB database (http://www.uniprot.
org/uniprot/Q96G97), 398 amino acids seipin protein has
five domains including 2 cytoplasmic [1-26aa and 264-
398aa], 2 transmembrane [27-47aa and 243-263aa] and a
luminal [48-242aa]. So far 31 mutations are reported in
BSCL2 gene including 12 missense/nonsense, 4 small
insertions, 4 small deletions, 7 splice-site mutations and 4
complex rearrangements causing related phenotypes as
summarized in Table 2.
More than three hundred cases of BSCL have been
reported in the medical literature with an estimated preva-
lence of 1 in 10 million people in USA [35]. However this
Table 2 List of mutations in BSCL2 gene so far
Exon cDNA Protein Phenotype References
Missense/Nonsense
2 c.232A>G p.Thr78Ala CGL2 [27]
2 c.263A>G p.Asn88Ser dHMN [16,18,28]
2 c.269C>T p.Ser90Leu dHMN, CMT2 [18,29,30]
2 c.269C>G p.Ser90Trp dHMN, CMT2 [22]
2 c.272T>C p.Leu91Pro CGL2 [27]
3 c.412C>T p.Arg138X CGL2 [5]
4 c.560A>G p.Tyr187Cys CGL2 [15]
4 c.565G>T p.Glu189X CGL2 [14]
5 c.634G>C p.Ala212Pro CGL2 [5,25]
6 c.684C>G p. Tyr228X CGL2 [7]
7 c.823C>T p.Arg275X CGL2 [31]
10 c.1171C>T p.Gln391X CGL2 [27]
Insertion
1 c.154_155insTT p.Tyr53SerfsX39 CGL2 [7]
3 c.301_302insAA p.Met101LysfsX10 CGL2 [5]
3 c.325insA p.Thr109AsnfsX5 CGL2 [5]
6 c.782dupG p.Ile262HisfsX12 CGL2 [7]
Deletion
3 c.315_316delGT p.Tyr106SerfsX7 CGL2 [5]
3 c.317_321delATCGT p. Tyr106CysfsX6 CGL2 [5,25]
5 c.636delC p.Tyr213ThrfsX20 CGL2 [5]
5 c.652_662del11 p.Ala218TrpfsX51 CGL2 [32]
Splice-site
IVS2 -11A>G Exon skipping Protein truncation CGL2 [33]
IVS4 +1G>A Exon skipping Protein truncation CGL2 [5]
IVS5 -2A>G Exon skipping Protein truncation CGL2 [27]
IVS5- 2A>C Exon skipping Protein truncation CGL2 [34]
IVS6 +5G>A Exon skipping Protein truncation CGL2 [5]
IVS6 -3C>G Exon skipping Protein truncation CGL2 [5,25]
IVS6 -2A>G Exon skipping Protein truncation CGL2 [7]
Complex rearrangements
1 c.192_193delCCinsGGA CGL2 [5,25]
1 c.193delCinsGGA CGL2 [7]
4-6 Deletion of exons 4-6 CGL2 [5]
5-6 Indel leading exons 5–6 deletion CGL2 [5]
dHMN= distal motor hereditary neuropathy; CMT2 = Charcot-Marie-Tooth type 2; CGL2 = Congenital generalized lipodystrophy type 2.
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the world like Lebanon, Brazil, Portugal and Sultanate of
Oman with an estimated prevalence of 1:25000 to
1:1000000 [36]. The incidence data of BSCL and many
other rare disorders are not available from Pakistan partly
due to lack of disease registry database systems and non-
availability of neonatal screening programs in the hospitals.Generally, in families segregating autosomal recessive
disorders, high frequency of consanguineous marriages
may increase the frequency of homozygotes in the popu-
lation leading to increased incidence of certain lesions,
their founder effect and also the appearance of new
mutations [37]. Although most causative mutations in
Mendelian diseases are reported in single families,
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populations than others. Few examples of such prevalent
mutations may be observed in Wilson’s disease [38],
hemophilia [39], Hurler disease [37] and thalassemia
[40]. Knowledge of the differences in the worldwide dis-
tribution of particular mutations may help to design
shortcuts for genetic diagnosis and screening of relevant
inherited diseases.
Conclusion
The identified mutation c.636delC (p.Tyr213ThrfsX20) in
exon 5 of BSCL2 gene is the first report of CGL2 from
Pakistan. The current study extends the body of evidence
that describes the role of BSCL2 in congenital generalized
lipodystrophy and association of loss-of-function muta-
tions with severe lipodystrophy phenotype. The clinical
features in our patients are similar to CGL2 phenotype
but lack of motor neuropathies that are usually associated
with Silver syndrome and Charcot-Marie-Tooth disease
were not observed in our case. Understanding the mo-
lecular defects of BSCL2 gene in the patients can be help-
ful in the genetic counseling and prenatal diagnosis of
affected families and may help to improve specific thera-
peutic interventions.
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